BCMA+ cells are recognized by the anti-BCMA CAR on infused T cells, which upon engagement activate cytotoxic effector functions (perforin/granzyme and Fas/FasL), causing apoptosis/lysis of BCMA-expressing plasmablasts/plasma cells.